CLINICAL_TRIALS
research
· 2026-02-12
Clinical Trial Update: Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003) [Phase 1]
Summary
A Phase 1 multiple-dose study of MK-2828 in participants with Type 2 diabetes is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: RECRUITING